Eduard Sergienko

ORCID: 0009-0003-2595-2227
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Alkaline Phosphatase Research Studies
  • Biochemical and Molecular Research
  • Receptor Mechanisms and Signaling
  • Analytical Chemistry and Chromatography
  • Neuropeptides and Animal Physiology
  • Cellular transport and secretion
  • Biochemical Acid Research Studies
  • Protein Tyrosine Phosphatases
  • Particle accelerators and beam dynamics
  • Ubiquitin and proteasome pathways
  • Nuclear Physics and Applications
  • Various Chemistry Research Topics
  • Peptidase Inhibition and Analysis
  • Enzyme Structure and Function
  • Pharmacological Receptor Mechanisms and Effects
  • ATP Synthase and ATPases Research
  • Heterotopic Ossification and Related Conditions
  • Radiopharmaceutical Chemistry and Applications
  • Genomics, phytochemicals, and oxidative stress
  • Analytical Chemistry and Sensors
  • Microtubule and mitosis dynamics
  • Retinal Development and Disorders
  • Parathyroid Disorders and Treatments
  • Cell death mechanisms and regulation
  • Superconducting Materials and Applications

Sanford Burnham Prebys Medical Discovery Institute
2016-2025

Discovery Institute
2016-2025

Institute of Psychology
2021-2023

In-Q-Tel
2015

Maastricht University
2014

University of Birmingham
2014

Joint Center for Structural Genomics
2011

ID Genomics (United States)
2010

Institute for Medical Research
2007-2009

Genomics (United Kingdom)
2009

ABSTRACT Medial vascular calcification (MVC) is a pathological phenomenon that causes stiffening and can lead to heart failure; it common variety of conditions, including aging, chronic kidney disease, diabetes, obesity, rare genetic diseases. These conditions share the feature tissue-nonspecific alkaline phosphatase (TNAP) upregulation in vasculature. To evaluate role TNAP MVC, we developed mouse model overexpresses human smooth muscle cells an X-linked manner. Hemizygous overexpressor male...

10.1002/jbmr.2420 article EN Journal of Bone and Mineral Research 2014-11-27

Abstract Pharmacological strategies that boost intracellular NAD + are highly coveted for their therapeutic potential. One approach is activation of nicotinamide phosphoribosyltransferase (NAMPT) to increase production mononucleotide (NMN), the predominant precursor in mammalian cells. A high-throughput screen NAMPT activators and hit-to-lead campaign yielded SBI-797812, a compound structurally similar active-site directed inhibitors blocks binding these NAMPT. SBI-797812 shifts reaction...

10.1038/s41467-019-11078-z article EN cc-by Nature Communications 2019-07-19

Ectopic calcification in PXE integrates both local and systemic perturbations of extracellular ATP metabolism can be attenuated with a TNAP inhibitor.

10.1126/scitranslmed.aal1669 article EN Science Translational Medicine 2017-06-07

We report the characterization and optimization of drug-like small molecule inhibitors tissue-nonspecific alkaline phosphatase (TNAP), an enzyme critical for regulation extracellular matrix calcification during bone formation growth. High-throughput screening (HTS) a library led to identification arylsulfonamides as potent selective TNAP. Critical structural requirements activity were determined, compounds subsequently profiled in vitro bioavailability parameters including metabolic...

10.1021/jm900383s article EN Journal of Medicinal Chemistry 2009-10-12

Benzoylformate decarboxylase is a member of the family enzymes that are dependent on cofactor thiamin diphosphate. A structure this enzyme binding (R)-mandelate, competitive inhibitor, suggests at least two hydrogen bonds formed between substrate, benzoylformate, and active site side chains. The first carboxylate group benzoylformate hydroxyl S26, second carbonyl substrate an imidazole nitrogen H70. Steady-state kinetic studies indicate catalytic parameters strongly affected in three...

10.1021/bi026490k article EN Biochemistry 2003-01-30

Hepatic cystogenesis in polycystic liver disease is associated with increased levels of cyclic adenosine monophosphate (cAMP) cholangiocytes lining cysts. Takeda G protein receptor 5 (TGR5), a protein–coupled bile acid receptor, linked to cAMP and expressed cholangiocytes. Therefore, we hypothesized that TGR5 might contribute progression. We examined expression Gα proteins cultured livers animal models humans disease. In vitro , assessed cholangiocyte proliferation, levels, cyst growth...

10.1002/hep.29284 article EN Hepatology 2017-05-25

Autophagy is an evolutionarily conserved process for catabolizing damaged proteins and organelles in a lysosome-dependent manner. Dysregulation of autophagy may cause various diseases, such as cancer neurodegeneration. However, the relevance to diseases remains controversial because limited availability chemical modulators. Herein, authors developed fluorescence-based assay measuring activity protease, autophagin-1(Atg4B). The employs novel reporter substrate Atg4B composed natural (LC3B)...

10.1177/1087057110392996 article EN cc-by-nc-nd SLAS DISCOVERY 2011-01-19

Glucose-6-phosphate dehydrogenase (G6PD) is the key enzyme of pentose phosphate pathway, converting glucose-6-phosphate to 6-phosphoglucono-δ-lactone with parallel reduction NADP(+). Several human diseases, including cancer, are associated increased G6PD activity. To date, only a few inhibitors have been available. However, adverse side effects and high IC(50) values hamper their use as therapeutics basic research probes. In this study, we developed high-throughput screening assay identify...

10.1177/1087057112462131 article EN cc-by-nc-nd SLAS DISCOVERY 2012-09-30

Herein we present the outcome of a high throughput screening (HTS) campaign-based strategy for rapid identification and optimization selective general chemotypes both kappa (κ) opioid receptor (KOR) activation inhibition. In this program, have developed potent antagonists (IC(50) < 120 nM) or agonists binding affinity (K(i) 3 nM). contrast to many important KOR ligands, compounds presented here are highly modular, readily synthesized and, in most cases, achiral. The four new hold promise...

10.1021/cn200128x article EN ACS Chemical Neuroscience 2012-01-20

// Paul D. Hanavan 1 , Chad R. Borges 2 Benjamin A. Katchman Douglas O. Faigel 3 Thai H. Ho Chen-Ting Ma 4 Eduard Sergienko Nathalie Meurice Joachim L. Petit F. Lake School of Life Sciences, Mayo Clinic Collaborative Research Building, Arizona State University, Scottsdale, AZ, USA Center for Personalized Diagnostics, Biodesign Institute, Tempe, Arizona, Conrad Prebys Chemical Genomics, Sanford-Burnham Medical La Jolla, CA, Correspondence to: Lake, e-mail: douglas.lake@asu.edu Keywords:...

10.18632/oncotarget.4099 article EN Oncotarget 2015-06-01

A limitation of current antiplatelet therapies is their inability to separate thrombotic events from bleeding occurrences. better understanding the molecular mechanisms leading platelet activation important for development improved therapies. Recently, protein tyrosine phosphatases have emerged as critical regulators function.This first report implicating dual-specificity phosphatase 3 (DUSP3) in signaling and thrombosis. This highly expressed human mouse platelets. Platelets DUSP3-deficient...

10.1161/circulationaha.114.010186 article EN Circulation 2014-12-18

Ubiquitin-like (Ubl) post-translational modifications are potential targets for therapeutics. However, the only known mechanism inhibiting a Ubl-activating enzyme is through targeting its ATP-binding site. Here we identify an allosteric inhibitory site in small ubiquitin-like modifier (SUMO)-activating (E1). This was unexpected because both it and analogous sites deeply buried all previously solved structures of E1s modifiers (Ubl). The inhibitor not suppresses SUMO E1 activity, but also...

10.1016/j.chembiol.2018.10.026 article EN publisher-specific-oa Cell chemical biology 2018-12-20

We report the discovery and validation of a series benzoisothiazolones as potent inhibitors phosphomannose isomerase (PMI), an enzyme that converts mannose-6-phosphate (Man-6-P) into fructose-6-phosphate (Fru-6-P) and, more importantly, competes with phosphomannomutase 2 (PMM2) for Man-6-P, diverting this substrate from critical protein glycosylation events. In congenital disorder type Ia, PMM2 activity is compromised; thus, PMI inhibition potential strategy development therapeutics....

10.1021/jm101401a article EN Journal of Medicinal Chemistry 2011-05-03

Summary Metabolic syndrome and excessive alcohol consumption result in liver injury fibrosis, which is characterized by increased collagen production activated Hepatic Stellate Cells (HSCs). LARP6, an RNA-binding protein, was shown to facilitate production. However, LARP6 expression functionality as a regulator of fibrosis development disease relevant model remains elusive. By using snRNA-sequencing, we show that upregulated mainly HSCs patients. Moreover, knockdown human suppresses...

10.1101/2025.01.16.633226 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2025-01-18

Yeast pyruvate decarboxylase (YPDC), in addition to forming its metabolic product acetaldehyde, can also carry out carboligase reactions which the central enamine intermediate reacts with acetaldehyde or (instead of usual proton electrophile), resulting formation acetoin and acetolactate, respectively (typically, 1% total reaction). Due common mechanism shared by acetaldehyde-forming through decarboxylation, a detailed analysis rates stereochemistry products formed E477Q, D28A, D28N active...

10.1021/bi002856m article EN Biochemistry 2001-05-31
Coming Soon ...